Results 151 to 160 of about 77,371 (194)

Impact of an optimized care model for advanced HIV disease: a non-randomized cluster study in Malawi. [PDF]

BMC Public Health
Maphosa T, Denoeud-Ndam L, Chilikutali L, Matiya E, Wilson B, Nyirenda R, Mayi A, Machekano R, Tiam A.   +8 more
europepmc   +1 more source

Dietary Influence on Anthropometric Measures, Clinical Outcomes, and Quality of Life in Individuals with HIV Receiving Antiretroviral Therapy: A Protocol.

J Pharm Bioallied Sci
Paul PY, Singh N, Komarraju SL.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

AIDS related opportunistic infections, going but not gone

Archives of Pharmacal Research, 2002
It is now more than two decades since the AIDS epidemic began with a cluster of Pneumocystis carinii pneumonia (PCP) in a community of homosexual men. Since then, many other infections have been characterized as opportunistic infections secondary to HIV infection. These include, but are not limited to, infections with Toxoplasma gondii, Cytomegalovirus
Rafik, Samuel, Robert L, Bettiker, Byungse, Suh   +2 more
openaire   +2 more sources

Experimental Results on Chloroquine and AIDS-Related Opportunistic Infections

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
Apart from its antiretroviral effects, chloroquine (CQ) has other properties that may be of interest in setting of HIV infection. First, it is an anti-inflammatory drug and, second, it may help to prevent several AIDS-related opportunistic infections.
Boelaert JR, Appelberg R, Gomes MS, BLASI, Elisabetta, Mazzolla R, Grosset J, Lounis N, Soteriadou K, Thiakaki M, Taramelli D, Tognazioli C.   +10 more
openaire   +3 more sources

Patients at Risk for AIDS-Related Opportunistic Infections

New England Journal of Medicine, 1985
We studied 81 men (79 homosexuals and 2 drug abusers) with persistent lymphadenopathy to determine whether those at risk for AIDS-related opportunistic infections could be identified prospectively. (Sixty-nine of 76 [91 per cent] had antibodies to human T-cell lymphotropic virus Type III [HTLV-III], and 76 of 79 [96 per cent] had abnormal T4/T8 cell ...
H W, Murray, J K, Hillman, B Y, Rubin, C D, Kelly, J L, Jacobs, L W, Tyler, D M, Donelly, S M, Carriero, J H, Godbold, R B, Roberts   +9 more
openaire   +2 more sources

Recent Advances in the Management of AIDS-related Opportunistic Infections

Annals of Internal Medicine, 1994
• Secondary infections remain the leading cause of death in patients with the acquired immunodeficiency syndrome (AIDS). Dealing with the rapidly evolving spectrum of infectious problems seen in patients with AIDS requires knowledge of current therapeutic and prophylactic strategies.
H. Clifford Lane, Barbara E. Laughon, Judith Falloon, Joseph A. Kovacs, Richard T. Davey, Michael A. Polis, Henry Masur   +6 more
openaire   +1 more source

Microsporidiosis as an AIDS-Related Opportunistic Infection

Clinical Infectious Diseases, 1995
The clinical manifestations of AIDS-related microsporidiosis range from mild or asymptomatic infections to debilitating illness involving the gastrointestinal, respiratory, or urogenital tracts or the eyes. Intestinobiliary infections with Enterocytozoon bieneusi are the most common microsporidial diseases, but disseminated infections with ...
openaire   +2 more sources

Tissue Diagnosis of Selected AIDS-Related Opportunistic Infections

The American Journal of Surgical Pathology, 1987
Opportunistic infections are the most common initial manifestations of AIDS and, in many instances, are first encountered in surgical specimens. Pneumocystis carinii pneumonitis is by far the most frequent infection seen in biopsy specimens of AIDS patients. Most pathologists are familiar with its histopathologic presentations from previous experience.
openaire   +2 more sources

Systemic Antifungal Agents Against AIDS-Related Opportunistic Infections: Current Status and Emerging Drugs in Development

Current Medicinal Chemistry, 1999
No effective drug was available for the treatment of systemic fungal infections until the discovery of Amphotericin 8 in 1953. Since then flucytosine, azoles and later the triazoles, have now become available. The current interest in the development of new antifungal agents can partially be explained by the dramatic rise in the number of AIDS cases ...
S Y, Ablordeppey, P, Fan, J H, Ablordeppey, L, Mardenborough   +3 more
openaire   +2 more sources